These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1351 related items for PubMed ID: 32156279

  • 1. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, Shen H, Wang Z, Zhou Y, Liu X.
    Cardiovasc Diabetol; 2020 Mar 10; 19(1):31. PubMed ID: 32156279
    [Abstract] [Full Text] [Related]

  • 2. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ.
    Cardiovasc Diabetol; 2020 Jul 08; 19(1):108. PubMed ID: 32641127
    [Abstract] [Full Text] [Related]

  • 3. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y.
    Cardiovasc Diabetol; 2020 Jul 23; 19(1):116. PubMed ID: 32703284
    [Abstract] [Full Text] [Related]

  • 4. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S, Chen Q, Chen X, Hou J, Chen Y, Long Y, Yang S, Qi L, Su H, Huang W, Liu H, Zhang Z, Cai L.
    Cardiovasc Diabetol; 2022 Aug 05; 21(1):145. PubMed ID: 35932019
    [Abstract] [Full Text] [Related]

  • 5. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Zhao Q, Cheng YJ, Xu YK, Zhao ZW, Liu C, Sun TN, Zhou YJ.
    Cardiovasc Diabetol; 2021 Sep 18; 20(1):190. PubMed ID: 34537077
    [Abstract] [Full Text] [Related]

  • 6. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY, Zhang R, Xu JH.
    Cardiovasc Diabetol; 2020 Jun 13; 19(1):80. PubMed ID: 32534586
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
    Chen Q, Xiong S, Ye T, Gao Y, Wang J, Li X, Li Y, Cui C, Liu H, Zhang Z, Cai L, Zheng J.
    Cardiovasc Diabetol; 2024 May 16; 23(1):172. PubMed ID: 38755609
    [Abstract] [Full Text] [Related]

  • 8. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ.
    J Atheroscler Thromb; 2021 Nov 01; 28(11):1175-1194. PubMed ID: 33191314
    [Abstract] [Full Text] [Related]

  • 9. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y.
    Cardiovasc Diabetol; 2021 Jul 08; 20(1):137. PubMed ID: 34238294
    [Abstract] [Full Text] [Related]

  • 10. Triglyceride-glucose index as a predictor of cardiac adverse events in acute coronary syndrome patients undergoing percutaneous coronary intervention: role of diabetes.
    Khalaji A, Behnoush AH, Pasebani Y, Rafati A, Mahmoodi T, Arzhangzadeh A, Shamshiri Khamene S, MohammadKhawajah I, Mehrani M, Vasheghani-Farahani A, Masoudkabir F, Najafi K, Askari MK, Harrison A, Nelson JR, Hosseini K, Hernandez AV.
    BMC Cardiovasc Disord; 2024 Sep 27; 24(1):514. PubMed ID: 39333881
    [Abstract] [Full Text] [Related]

  • 11. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C.
    Cardiovasc Diabetol; 2019 Nov 13; 18(1):150. PubMed ID: 31722708
    [Abstract] [Full Text] [Related]

  • 12. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome.
    Wang C, Liao P, Tang C, Chen C, Zhang X.
    Front Endocrinol (Lausanne); 2024 Nov 13; 15():1423227. PubMed ID: 39257901
    [Abstract] [Full Text] [Related]

  • 13. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
    Zhang Y, Chu C, Zhong Z, Luo YB, Ning FF, Guo N.
    Front Endocrinol (Lausanne); 2023 Nov 13; 14():1101952. PubMed ID: 36875470
    [Abstract] [Full Text] [Related]

  • 14. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S, Chen Q, Zhang Z, Chen Y, Hou J, Cui C, Cheng L, Su H, Long Y, Yang S, Qi L, Chen X, Liu H, Cai L.
    Cardiovasc Diabetol; 2022 Jun 24; 21(1):115. PubMed ID: 35751060
    [Abstract] [Full Text] [Related]

  • 15. Association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute coronary syndrome: results from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome project.
    Wang W, Yang J, Wang K, Niu J, Liu Y, Ge H, CCC-ACS Investigators.
    Cardiovasc Diabetol; 2024 May 15; 23(1):170. PubMed ID: 38750553
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X, Sun Y, Cheng Y, Shen H, Gao F, Qi J, Yang L, Wang Z, Shi D, Liu Y, Liu X, Zhou Y.
    Lipids Health Dis; 2020 Nov 16; 19(1):240. PubMed ID: 33198752
    [Abstract] [Full Text] [Related]

  • 17. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S, Zhao Z, Huang X, Ma M, Yang Z, Fan C, Han H, Wang Z, Shi D, Zhou Y.
    Cardiovasc Diabetol; 2023 Oct 27; 22(1):286. PubMed ID: 37891647
    [Abstract] [Full Text] [Related]

  • 18. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China.
    Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, Zhao XQ, Li W, Li H.
    Cardiovasc Diabetol; 2021 Feb 11; 20(1):43. PubMed ID: 33573649
    [Abstract] [Full Text] [Related]

  • 19. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
    Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H.
    Cardiovasc Diabetol; 2021 Jun 28; 20(1):131. PubMed ID: 34183007
    [Abstract] [Full Text] [Related]

  • 20. The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.
    Mao Q, Zhou D, Li Y, Wang Y, Xu SC, Zhao XH.
    Dis Markers; 2019 Jun 28; 2019():6891537. PubMed ID: 31281548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.